Clinical Trial Update: Aldara for the Treatment of Large and/or Multiple sBCC [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Aldara for large or multiple superficial basal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Aldara (imiquimod)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Carcinoma, Basal Cell | Phase 3 | Status: COMPLETED